Cargando…
Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion
Increased levels of extracellular superoxide dismutase (ecSOD) induced by preconditioning or gene therapy protect the heart from ischemia/reperfusion injury. To elucidate the mechanism responsible for this action, we studied the effects of increased superoxide scavenging on nitric oxide (NO) bioavai...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505528/ https://www.ncbi.nlm.nih.gov/pubmed/23099819 http://dx.doi.org/10.1007/s00395-012-0305-1 |
_version_ | 1782250773808152576 |
---|---|
author | Obal, Detlef Dai, Shujing Keith, Rachel Dimova, Neviana Kingery, Justin Zheng, Yu-Ting Zweier, Jay Velayutham, Murugesan Prabhu, Sumanth D. Li, Qianghong Conklin, Daniel Yang, Dan Bhatnagar, Aruni Bolli, Roberto Rokosh, Gregg |
author_facet | Obal, Detlef Dai, Shujing Keith, Rachel Dimova, Neviana Kingery, Justin Zheng, Yu-Ting Zweier, Jay Velayutham, Murugesan Prabhu, Sumanth D. Li, Qianghong Conklin, Daniel Yang, Dan Bhatnagar, Aruni Bolli, Roberto Rokosh, Gregg |
author_sort | Obal, Detlef |
collection | PubMed |
description | Increased levels of extracellular superoxide dismutase (ecSOD) induced by preconditioning or gene therapy protect the heart from ischemia/reperfusion injury. To elucidate the mechanism responsible for this action, we studied the effects of increased superoxide scavenging on nitric oxide (NO) bioavailability in a cardiac myocyte-specific ecSOD transgenic (Tg) mouse. Results indicated that ecSOD overexpression increased cardiac myocyte-specific ecSOD activity 27.5-fold. Transgenic ecSOD was localized to the sarcolemma and, notably, the cytoplasm of cardiac myocytes. Ischemia/reperfusion injury was attenuated in ecSOD Tg hearts, in which infarct size was decreased and LV functional recovery was improved. Using the ROS spin trap, DMPO, electron paramagnetic resonance (EPR) spectroscopy demonstrated a significant decrease in ROS in Tg hearts during the first 20 min of reperfusion. This decrease in ROS was accompanied by an increase in NO production determined by EPR using the NO spin trap, Fe-MGD. Attenuated ROS in ecSOD Tg myocytes was also supported by decreased production of peroxynitrite (ONOO(−)). Increased NO bioavailability was confirmed by attenuated guanylate cyclase-dependent (p-VASP) signaling. In conclusion, attenuation of ROS levels by cardiac-specific ecSOD overexpression increases NO bioavailability in response to ischemia/reperfusion and protects against reperfusion injury. These findings are the first to demonstrate increased NO bioavailability with attenuation of ROS by direct measurement of these reactive species (EPR, reactive fluorescent dyes) with cardiac-specific ecSOD expression. This is also the first indication that the predominantly extracellular SOD isoform is capable of cytosolic localization that affects myocardial intracellular signal transduction and function. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00395-012-0305-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-3505528 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-35055282012-11-28 Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion Obal, Detlef Dai, Shujing Keith, Rachel Dimova, Neviana Kingery, Justin Zheng, Yu-Ting Zweier, Jay Velayutham, Murugesan Prabhu, Sumanth D. Li, Qianghong Conklin, Daniel Yang, Dan Bhatnagar, Aruni Bolli, Roberto Rokosh, Gregg Basic Res Cardiol Original Contribution Increased levels of extracellular superoxide dismutase (ecSOD) induced by preconditioning or gene therapy protect the heart from ischemia/reperfusion injury. To elucidate the mechanism responsible for this action, we studied the effects of increased superoxide scavenging on nitric oxide (NO) bioavailability in a cardiac myocyte-specific ecSOD transgenic (Tg) mouse. Results indicated that ecSOD overexpression increased cardiac myocyte-specific ecSOD activity 27.5-fold. Transgenic ecSOD was localized to the sarcolemma and, notably, the cytoplasm of cardiac myocytes. Ischemia/reperfusion injury was attenuated in ecSOD Tg hearts, in which infarct size was decreased and LV functional recovery was improved. Using the ROS spin trap, DMPO, electron paramagnetic resonance (EPR) spectroscopy demonstrated a significant decrease in ROS in Tg hearts during the first 20 min of reperfusion. This decrease in ROS was accompanied by an increase in NO production determined by EPR using the NO spin trap, Fe-MGD. Attenuated ROS in ecSOD Tg myocytes was also supported by decreased production of peroxynitrite (ONOO(−)). Increased NO bioavailability was confirmed by attenuated guanylate cyclase-dependent (p-VASP) signaling. In conclusion, attenuation of ROS levels by cardiac-specific ecSOD overexpression increases NO bioavailability in response to ischemia/reperfusion and protects against reperfusion injury. These findings are the first to demonstrate increased NO bioavailability with attenuation of ROS by direct measurement of these reactive species (EPR, reactive fluorescent dyes) with cardiac-specific ecSOD expression. This is also the first indication that the predominantly extracellular SOD isoform is capable of cytosolic localization that affects myocardial intracellular signal transduction and function. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00395-012-0305-1) contains supplementary material, which is available to authorized users. Springer-Verlag 2012-10-26 2012 /pmc/articles/PMC3505528/ /pubmed/23099819 http://dx.doi.org/10.1007/s00395-012-0305-1 Text en © The Author(s) 2012 https://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Original Contribution Obal, Detlef Dai, Shujing Keith, Rachel Dimova, Neviana Kingery, Justin Zheng, Yu-Ting Zweier, Jay Velayutham, Murugesan Prabhu, Sumanth D. Li, Qianghong Conklin, Daniel Yang, Dan Bhatnagar, Aruni Bolli, Roberto Rokosh, Gregg Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion |
title | Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion |
title_full | Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion |
title_fullStr | Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion |
title_full_unstemmed | Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion |
title_short | Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion |
title_sort | cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion |
topic | Original Contribution |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505528/ https://www.ncbi.nlm.nih.gov/pubmed/23099819 http://dx.doi.org/10.1007/s00395-012-0305-1 |
work_keys_str_mv | AT obaldetlef cardiomyocyterestrictedoverexpressionofextracellularsuperoxidedismutaseincreasesnitricoxidebioavailabilityandreducesinfarctsizeafterischemiareperfusion AT daishujing cardiomyocyterestrictedoverexpressionofextracellularsuperoxidedismutaseincreasesnitricoxidebioavailabilityandreducesinfarctsizeafterischemiareperfusion AT keithrachel cardiomyocyterestrictedoverexpressionofextracellularsuperoxidedismutaseincreasesnitricoxidebioavailabilityandreducesinfarctsizeafterischemiareperfusion AT dimovaneviana cardiomyocyterestrictedoverexpressionofextracellularsuperoxidedismutaseincreasesnitricoxidebioavailabilityandreducesinfarctsizeafterischemiareperfusion AT kingeryjustin cardiomyocyterestrictedoverexpressionofextracellularsuperoxidedismutaseincreasesnitricoxidebioavailabilityandreducesinfarctsizeafterischemiareperfusion AT zhengyuting cardiomyocyterestrictedoverexpressionofextracellularsuperoxidedismutaseincreasesnitricoxidebioavailabilityandreducesinfarctsizeafterischemiareperfusion AT zweierjay cardiomyocyterestrictedoverexpressionofextracellularsuperoxidedismutaseincreasesnitricoxidebioavailabilityandreducesinfarctsizeafterischemiareperfusion AT velayuthammurugesan cardiomyocyterestrictedoverexpressionofextracellularsuperoxidedismutaseincreasesnitricoxidebioavailabilityandreducesinfarctsizeafterischemiareperfusion AT prabhusumanthd cardiomyocyterestrictedoverexpressionofextracellularsuperoxidedismutaseincreasesnitricoxidebioavailabilityandreducesinfarctsizeafterischemiareperfusion AT liqianghong cardiomyocyterestrictedoverexpressionofextracellularsuperoxidedismutaseincreasesnitricoxidebioavailabilityandreducesinfarctsizeafterischemiareperfusion AT conklindaniel cardiomyocyterestrictedoverexpressionofextracellularsuperoxidedismutaseincreasesnitricoxidebioavailabilityandreducesinfarctsizeafterischemiareperfusion AT yangdan cardiomyocyterestrictedoverexpressionofextracellularsuperoxidedismutaseincreasesnitricoxidebioavailabilityandreducesinfarctsizeafterischemiareperfusion AT bhatnagararuni cardiomyocyterestrictedoverexpressionofextracellularsuperoxidedismutaseincreasesnitricoxidebioavailabilityandreducesinfarctsizeafterischemiareperfusion AT bolliroberto cardiomyocyterestrictedoverexpressionofextracellularsuperoxidedismutaseincreasesnitricoxidebioavailabilityandreducesinfarctsizeafterischemiareperfusion AT rokoshgregg cardiomyocyterestrictedoverexpressionofextracellularsuperoxidedismutaseincreasesnitricoxidebioavailabilityandreducesinfarctsizeafterischemiareperfusion |